Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1638565 | PMC |
| http://dx.doi.org/10.1136/bmj.1.6004.283-c | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ameliorating freezing of gait with levodopa treatment: a lesson from an illustrative case of progressive supranuclear palsy.
Acta Neurol Belg
December 2024
Department of Neurology, Soon-chun-hyang University Seoul Hospital, Soon-chun-hyang University School of Medicine, Seoul, Republic of Korea.
Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross-Sectional Observational Study.
Mov Disord Clin Pract
January 2025
Neuroscience Axis, CHU de Québec-Université Laval Research Centre, Québec City, QC, Canada.
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease - Authors' reply.
Lancet Neurol
September 2024
University of Toulouse 3, University Hospital of Toulouse, INSERM, Clinical Investigation Center CIC1436, Department of Neurosciences and Department of Clinical Pharmacology, Toulouse, France; NS-Park/FCRIN Network, Toulouse, France.
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease.
Lancet Neurol
September 2024
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Beijing Key Laboratory of Neurostimulation, Beijing, China. Electronic address:
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease.
Lancet Neurol
September 2024
Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!